Big Pharma And Psychedelic Medicine: Eli Lilly’s $3.8 Billion Bet

On July 16, 2026, Eli Lilly announced it would acquire AtaiBeckley for up to $3.8 billion — $2.8 billion up front, with another $1 billion in milestone-linked contingent value rights. The candidate drug is BPL-003…

Continue Reading

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *